Ho Chao-Chi, Lin Ching-Kai, Yang Ching-Yao, Chang Lih-Yu, Lin Shu-Yung, Yu Chong-Jen
Department of Internal Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan.
Department of Internal Medicine, National Taiwan University Hospital, Hsin-Chu Branch, National Taiwan University College of Medicine, Hsin-Chu, Taiwan.
J Thorac Dis. 2016 Oct;8(Suppl 9):S690-S696. doi: 10.21037/jtd.2016.08.21.
The diagnosis and staging of patients with lung cancer has relied on tissue sampling. Endobronchial ultrasound (EBUS) is a minimally invasive procedure for the rapid and safe acquisition of tissue and can be done easily and repeatedly. EBUS transbronchial needle aspiration (TBNA) is now the standard for diagnosis of mediastinal and hilar lymphadenopathy and should be considered in patients who have a high probability of lymph node metastases without systemic involvement. EBUS also provides guidance for biopsy of peripheral lung lesions. Recent advances of EBUS with new techniques help to improve the diagnostic yield and decrease the complication rate and total procedure time.
肺癌患者的诊断和分期一直依赖于组织取样。支气管内超声（EBUS）是一种用于快速、安全获取组织的微创操作，且操作简便、可重复进行。EBUS经支气管针吸活检（TBNA）现已成为纵隔和肺门淋巴结病变诊断的标准方法，对于淋巴结转移可能性高但无全身转移的患者应考虑采用。EBUS还可为周围型肺病变的活检提供引导。EBUS与新技术的最新进展有助于提高诊断率、降低并发症发生率并缩短总操作时间。
